Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 5,276–5,300 of 7,816 matching trials · page 212 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Control and Intervention Programme on Alzheimer's Disease Risk Factors
NCT02772523
Lifestyle recommendations
Runs in: Spain · 1 site
NA
other
COMPLETED 409 Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
OTHER
2020-07-21
Multiregional rtfMRI Neurofeedback for the Prevention of Alzheimer's Disease (NPAD)
NCT03173846
Runs in: Spain · 1 site
NA
other
COMPLETED 90 Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
OTHER
2020-07-21
Caring for Persons With Dementia and Their Caregivers in the Community
NCT04479033
Multidisciplinary collaborative model of community care management
Runs in: Singapore · 1 site
NA
other
UNKNOWN 300 Duke-NUS Graduate Medical School
OTHER
2020-07-21
Evaluation and Characterization of Behavioural Disorders and Dementias by the Behavioural Dysexecutive Syndrome Inventory (BDSI)
NCT02819700
prevalence of behavioural dysexecutive syndrome
Runs in: France · 2 sites
NA
other
COMPLETED 49 Centre Hospitalier Universitaire, Amiens
OTHER
2020-07-20
Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1
NCT00476671
lumbar puncture, MRI, MRS
Runs in: Thailand · 1 site
NA
other
COMPLETED 100 The HIV Netherlands Australia Thailand Research Collaboration
OTHER
2020-07-17
Deep Brain Stimulation for Alzheimer's Disease
NCT03959124
Deep brain stimulation; Best medical treatment for Alzheimer's disease
Runs in: Taiwan · 1 site
NA
other
UNKNOWN 30 Buddhist Tzu Chi General Hospital
OTHER
2020-07-17
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).
NCT02670083
Crenezumab; Placebo
Runs in: Australia; Austria; Belgium; Bulgaria; Canada; Costa Rica... · 196 sites
PHASE3
anti-amyloid-antibody
TERMINATED 813 Hoffmann-La Roche
INDUSTRY
2020-07-16
A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
NCT03114657
Crenezumab; Placebo
Runs in: Argentina; Australia; Belgium; Brazil; Canada; China; Den... · 211 sites
PHASE3
anti-amyloid-antibody
TERMINATED 806 Hoffmann-La Roche
INDUSTRY
2020-07-16
A Goal-setting With Mentoring Lifestyle Modification Intervention to Reduce Risk of Dementia in Later Life
NCT03900156
goal-setting
Runs in: Taiwan · 1 site
NA
other
COMPLETED 94 Tzu-Ting Huang
OTHER
2020-07-15
Efficiency of Deep Transcranial Magnetic Stimulation on Patients With Mild Cognitive Impairment
NCT01464515
H-Coil Deep TMS; SHAM Coil TMS
Runs in: Israel · 1 site
PHASE1
other
UNKNOWN 30 Brainsway
INDUSTRY
2020-07-14
Association Between Cerebral Arterial Vascular Flow and Sleep Apnea in Neurodegenerative Alterations
NCT02578303
Vascular flow measurement by PC-MRI
Runs in: France · 1 site
NA
other
UNKNOWN 139 Central Hospital Saint Quentin
OTHER_GOV
2020-07-14
Transbucal Dexmedetomidine for Prevention of Sevoflurane Emergence Agitation in Pre-school Children
NCT02720705
Dexmedetomidine; saline
Runs in: Egypt · 1 site
PHASE2|PHASE3
other
COMPLETED 90 Assiut University
OTHER
2020-07-14
Mild Cognitive Impairment and Endurance Exercise in Parkinson's Disease
NCT03542474
High Intensity Endurance Exercise
Runs in: United States · 1 site
NA
other
COMPLETED 8 Northwestern University
OTHER
2020-07-14
Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly
NCT01951118
Donepezil
Runs in: United States · 1 site
PHASE4
symptomatic-cholinergic
COMPLETED 121 New York State Psychiatric Institute
OTHER
2020-07-13
Brain Sleep Deprivation MRI Effects (BEDTIME)
NCT02741505
Actigraph
Runs in: United States · 1 site
NA
other
WITHDRAWN 0 NYU Langone Health
OTHER
2020-07-13
An Open-Label Crenezumab Study in Participants With Alzheimer's Disease
NCT03491150
Crenezumab
Runs in: Australia; Canada; Finland; France; Germany; Hong Kong; I... · 66 sites
PHASE3
anti-amyloid-antibody
TERMINATED 149 Hoffmann-La Roche
INDUSTRY
2020-07-13
Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE)
NCT03891277
Ferrous succinate
Runs in: China · 1 site
PHASE2
other
UNKNOWN 1,006 Beijing Tiantan Hospital
OTHER
2020-07-13
A Extension Study to Evaluate Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Cardiac Amyloidosis
NCT02292186
Revusiran (ALN-TTRSC)
Runs in: Canada; United Kingdom; United States · 5 sites
PHASE2
other
COMPLETED 25 Alnylam Pharmaceuticals
INDUSTRY
2020-07-09
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
NCT03184467
Normal Saline 0.9%; GV1001 0.56 mg; GV1001 1.12 mg
Runs in: South Korea · 1 site
PHASE2
other
COMPLETED 96 GemVax & Kael
INDUSTRY
2020-07-09
Comparing Smartphone Technology and a Memory Strategy on Improving Prospective Memory in Alzheimer's Disease
NCT03384043
Smartphone Personal Assistant; Implementation Intention
Runs in: United States · 1 site
NA
other
COMPLETED 52 Baylor University
OTHER
2020-07-08
Study to Compare the Pharmacokinetics of Tricaprilin Formulations and a Placebo on Ketone Body Production
NCT03971123
Tricaprilin; Tricaprilin; Placebo; Tricaprilin
Runs in: Australia · 1 site
PHASE1
other
COMPLETED 32 Cerecin
INDUSTRY
2020-07-08
Study to Compare the Pharmacokinetics of Daily Administration of Tricaprilin on Ketone Body Production
NCT04268953
Tricaprilin
Runs in: United States · 1 site
PHASE1
other
COMPLETED 12 Cerecin
INDUSTRY
2020-07-08
Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease
NCT00277810
lecozotan SR (SRA-333)
Runs in: Argentina; Australia; Canada; Finland; France; Italy; Pol... · 83 sites
PHASE2|PHASE3
other
COMPLETED 250 Pfizer
INDUSTRY
2020-07-07
Cognitive Decline in Non-demented PD
NCT01340885
Strattera; Exelon; Placebo
Runs in: United States · 1 site
PHASE4
other
COMPLETED 9 Oregon Health and Science University
OTHER
2020-07-07
RAGE-Control: Teaching Emotional Self-regulation Through Videogame Play
NCT03270813
Relaxation training plus RAGE-Control; Relaxation training plus Sha...
Runs in: United States · 1 site
NA
other
UNKNOWN 40 Massachusetts General Hospital
OTHER
2020-07-07

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →